{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T13:35:33Z","timestamp":1776605733943,"version":"3.51.2"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/j.jsat.2020.108139","type":"journal-article","created":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T13:14:16Z","timestamp":1600694056000},"page":"108139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Revising our attitudes towards agonist medications and their diversion in a time of pandemic"],"prefix":"10.1016","volume":"119","author":[{"given":"Brandon","family":"del Pozo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Josiah D.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jsat.2020.108139_bb0005","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.drugpo.2017.11.021","article-title":"A qualitative study comparing physician-reported barriers to treating addiction using buprenorphine and extended-release naltrexone in U.S. office-based practices","volume":"54","author":"Andraka-Christou","year":"2018","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2020.108139_bb0010","doi-asserted-by":"crossref","DOI":"10.7326\/M20-1210","article-title":"When epidemics collide: Coronavirus disease 2019 (COVID-19) and the opioid crisis","author":"Becker","year":"2020","journal-title":"Annals of Internal Medicine"},{"key":"10.1016\/j.jsat.2020.108139_bb0015","doi-asserted-by":"crossref","first-page":"102722","DOI":"10.1016\/j.drugpo.2020.102722","article-title":"Unintentional drug overdose: Is more frequent use of non-prescribed buprenorphine associated with lower risk of overdose?","volume":"79","author":"Carlson","year":"2020","journal-title":"International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.jsat.2020.108139_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/ADM.0000000000000436","article-title":"The more things change: Buprenorphine\/naloxone diversion continues while treatment remains inaccessible","volume":"12","author":"Carroll","year":"2018","journal-title":"Journal of Addiction Medicine"},{"key":"10.1016\/j.jsat.2020.108139_bb0025","doi-asserted-by":"crossref","first-page":"102701","DOI":"10.1016\/j.drugpo.2020.102701","article-title":"Buprenorphine dispensing in an epicenter of the U.S. opioid epidemic: A case study of the rural risk environment in Appalachian Kentucky","author":"Cooper","year":"2020","journal-title":"The International Journal on Drug Policy"},{"issue":"4","key":"10.1016\/j.jsat.2020.108139_bb0030","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000679","article-title":"Opioid policy changes during the COVID-19 pandemic \u2014 And beyond","volume":"14","author":"Davis","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108139_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1940-0640-7-10","article-title":"Just call it \u201ctreatment\u201d","volume":"7","author":"Friedmann","year":"2012","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2020.108139_bb0040","series-title":"The New York Times","article-title":"Why the global recession could last a long time","author":"Goodman","year":"2020"},{"key":"10.1016\/j.jsat.2020.108139_bb0045","series-title":"The New York Times","article-title":"In shadow of pandemic, US drug overdoses resurge to record","author":"Katz","year":"2020"},{"key":"10.1016\/j.jsat.2020.108139_bb0050","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.jsat.2018.08.011","article-title":"Buprenorphine treatment formulations: Preferences among persons in opioid withdrawal management","volume":"94","author":"Kenney","year":"2018","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.jsat.2020.108139_bb0055","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.drugpo.2017.03.013","article-title":"How economic recessions and unemployment affect illegal drug use: A systematic realist literature review","volume":"44","author":"Nagelhout","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.jsat.2020.108139_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000703","article-title":"COVID-19 as a frying pan: The promise and perils of pandemic-driven reform","author":"del Pozo","year":"2020","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"10.1016\/j.jsat.2020.108139_bb0065","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1177\/1073110520935353","article-title":"Decriminalization of diverted buprenorphine in Burlington, Vermont and Philadelphia: An intervention to reduce opioid overdose deaths","volume":"48","author":"del Pozo","year":"2020","journal-title":"The Journal of Law, Medicine & Ethics"},{"key":"10.1016\/j.jsat.2020.108139_bb0070","series-title":"The Baltimore Sun","article-title":"Those addicted to heroin in Baltimore are being sent home with more methadone than ever amid the coronavirus pandemic","author":"Prudente","year":"2020"},{"key":"10.1016\/j.jsat.2020.108139_bb0075","doi-asserted-by":"crossref","first-page":"105785","DOI":"10.1016\/j.ypmed.2019.105785","article-title":"Patient perceptions of treatment with medication treatment for opioid use disorder (MOUD) in the Vermont hub-and-spoke system","volume":"128","author":"Rawson","year":"2019","journal-title":"Preventive Medicine"},{"issue":"1","key":"10.1016\/j.jsat.2020.108139_bb0080","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJMp1803982","article-title":"Methadone in primary care \u2014 One small step for congress, one giant leap for addiction treatment","volume":"379","author":"Samet","year":"2018","journal-title":"New England Journal of Medicine"},{"issue":"25","key":"10.1016\/j.jsat.2020.108139_bb0085","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1056\/NEJMc1610047","article-title":"Interim buprenorphine vs. waiting list for opioid dependence","volume":"375","author":"Sigmon","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2020.108139_bb0090","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.jsat.2020.108139_bb0095","author":"Substance Abuse and Mental Health Services Administration"},{"key":"10.1016\/j.jsat.2020.108139_bb0100","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2019.06.007","article-title":"Opioid users\u2019 willingness to receive prolonged-release buprenorphine depot injections for opioid use disorder","volume":"104","author":"Tompkins","year":"2019","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"1","key":"10.1016\/j.jsat.2020.108139_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMp1802741","article-title":"Primary care and the opioid-overdose crisis \u2014 Buprenorphine myths and realities","volume":"379","author":"Wakeman","year":"2018","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2020.108139_bb0110","series-title":"The Washington Post","article-title":"\u201cCries for help\u201d: Drug overdoses are soaring during the pandemic","author":"Wan","year":"2020"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220303962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547220303962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:52:32Z","timestamp":1760039552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547220303962"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12]]},"references-count":22,"alternative-id":["S0740547220303962"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108139","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revising our attitudes towards agonist medications and their diversion in a time of pandemic","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2020.108139","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108139"}}